Diagnostic News and Research

RSS

Early respiratory distress syndrome caused by SARS-CoV-2 in a newborn

A recent case report from the researchers at the University of São Paulo, published in the journal CLINICS, shows how newborns can also be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and develop serious symptoms, even though the most likely route of infection in such cases is still not completely clear.

14 Jun 2020

New test can detect the RNA of SARS-CoV-2 in patient samples in 30 minutes

A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in just 30 to 45 minutes, according to a new study published June 12, 2020 in the open-access journal PLOS ONE by Laura Lamb of the Beaumont Health System, Michigan, USA, and colleagues.

14 Jun 2020

JRC creates a database of COVID-19 diagnostic devices and test methods

As part of EU efforts to provide guidance on the use of coronavirus tests, the JRC has created a database of COVID-19 in vitro diagnostic devices and test methods that gathers information on available tests in one place.

12 Jun 2020

Scientists develop rapid bedside test for diagnosing nRDS in premature babies

Scientists at the University of Southampton's Zepler Institute for Photonics and Nanoelectronics are developing a rapid bedside test for diagnosing neonatal Respiratory Distress Syndrome (nRDS) in premature babies.

12 Jun 2020

QUT leads study to improve quality of life for children with congenital heart disease

QUT, in partnership with Children’s Health Queensland, will lead a nation-wide study to help health services support the long-term neurodevelopment and quality of life of children with congenital heart disease.

12 Jun 2020

Drug-like molecules offer a promising treatment for COVID-19

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.

12 Jun 2020

PCR Biosystems launches new kit for ultra-sensitive, high-throughput detection of SARS-CoV-2

PCR Biosystems, the UK-based PCR experts, today announced the launch of qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.

12 Jun 2020

New, reliable tests identified for detecting antibodies specific to SARS-CoV-2

A new analysis of blood sera taken from 63 COVID-19 patients, 71 controls, and various coronavirus-exposed animals provides strong support for the use of the SARS-CoV-2 virus' receptor-binding domain (RBD) as an antigen for reliable tests to detect antibodies to the virus.

12 Jun 2020

New training manual designed to help health care providers diagnose fetal alcohol spectrum disorders

Omar Rahman, M.D., director of the Munroe-Meyer Institute Department of Genetics at the University of Nebraska Medical Center, is part of a group that has created a training manual in both English and Spanish designed to help health care providers recognize and diagnose fetal alcohol spectrum disorders.

11 Jun 2020

WVU researchers develop new diagnostic and antibody tests for COVID-19

COVID-19 tests are in short supply. The companies that make the necessary chemicals--called reagents--can't keep up with demand. But researchers at West Virginia University are developing new tests on their own to identify who has COVID-19 now and who had it in the past but recovered.

11 Jun 2020

Experts clarify MS subtypes to improve care and access to treatments

An international committee of multiple sclerosis (MS) experts has clarified their previously published descriptors of the different courses of MS and disease activity.

11 Jun 2020

Cleveland Clinic receives $7.2 million to improve accuracy of MS diagnoses

The National Institutes of Health has awarded $7.2 million to a Cleveland Clinic-led research team to improve accuracy of multiple sclerosis (MS) diagnoses.

10 Jun 2020

Seroprevalence of IgM and IgG against SARS-CoV-2 in China

A new study published in the journal Nature Medicine in June 2020 reports the seroprevalence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across China. This may help to understand the actual prevalence of the virus in the current pandemic.

10 Jun 2020

UVA Health increasing access to food allergy clinical trials and expanding research

UVA Health and UVA Children's are increasing access to the latest food allergy clinical trials and expanding their cutting-edge food-allergy research, following their selection to a national food-allergy clinical network.

10 Jun 2020

New insights into causes for age-related orientation problems

Our sense of direction tends to decline with age. In the scientific journal "Nature Communications", researchers from the German Center for Neurodegenerative Diseases and experts from the USA report on new insights into the causes of this phenomenon.

10 Jun 2020

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Gilead Sciences, Inc. and Kite, a Gilead Company, are pleased to support the Virtual Edition of the 25th European Hematology Association Annual Congress, taking place 11–21 June 2020.

From Gilead Sciences, Inc. 10 Jun 2020

EKF opens for live chats at ENDO Online 2020

EKF Diagnostics, the global in vitro diagnostics company, announces that its online exhibition booth at this year’s ENDO Online 2020 is open for live chats on its range of diagnostics products for glycemic monitoring and ketosis testing from 10 - 17th June.

From EKF Diagnostics 10 Jun 2020

Promega announces CE marking for OncoMate MSI Dx Analysis System in Europe

Promega Corporation today announced CE marking for the OncoMate MSI Dx Analysis System as a new in vitro diagnostic medical device in Europe.

From Promega Corporation 10 Jun 2020

Cellular mechanophenotyping may provide more comprehensive view of the tumor

Our ability to predict who will get cancer, how a patient will respond to treatment, or if a patient will relapse is still quite limited. Despite advances in the detection of genetic mutations and the establishment of risk factors, such as age and genetic variants, it remains a great scientific and medical challenge.

9 Jun 2020

NIH grant awarded to UConn faculty to develop smartphone sensor to quantify tooth pain

Faculty from the Division of Endodontology and Department of Biomedical Engineering at the UConn School of Dental Medicine recently received a total award of $462,964 from the National Institutes of Dental and Craniofacial Research to test a novel way to quantify tooth pain and to develop a patient-friendly smartphone sensor to measure it.

9 Jun 2020